Dianthus Therapeutics (NASDAQ:DNTH) Stock Price Down 6.1% on Analyst Downgrade
Dianthus Therapeutics, Inc. (NASDAQ:DNTH – Get Free Report) shares traded down 6.1% on Tuesday after Robert W. Baird lowered their price target on the stock from $58.00 to $50.00. Robert W. Baird currently has an outperform rating on the stock. Dianthus Therapeutics traded as low as $18.64 and last traded at $18.86. 94,329 shares were […]
